Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris

Y. Futei, Masayuki Amagai, M. Sekiguchi, K. Nishifuji, Y. Fujii, T. Nishikawa

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Pemphigus vulgaris is an autoimmune blistering disease caused by autoantibodies against desmoglein 3, a member of the desmosomal cadherin family. These autoantibodies recognize conformation-dependent epitopes on desmoglein 3. In this study we attempted to map the conformational epitopes of desmoglein 3 in pemphigus vulgaris using recombinant desmoglein 3 produced by the baculovirus expression system. We developed a series of domain-swapped molecules between desmoglein 3 and desmoglein 1, which have similar structures but distinct epitopes. These were developed by substituting deleted segmental regions of desmoglein 3 by the corresponding desmoglein 1. Thus domain-swapped molecules containing desmoglein 3 residues 1-403, 1-161, 163-566, and 405-566 were constructed and used as competitors for competition enzyme-linked immunosorbent assay against the entire extracellular domain of desmoglein 3 with 25 pemphigus vulgaris sera. Considering more than 50% absorption as significant, residues 1-403 and 1-161 showed significant absorption in 24 out of 25 (96%) and 18 out of 25 (72%) pemphigus vulgaris sera, respectively, whereas only one serum and no sera showed significant absorption by residues 163-566 and 405-566, respectively. Furthermore, no apparent change in their major epitopes was seen during the time course in four pemphigus vulgaris cases tested. These findings indicate that the domain-swapping approach is useful for conformational epitope mapping in pemphigus and that amino-terminal residues 1-161, which are considered to include a region essential for cell-cell adhesion in cadherins, contain the critical residues of the conformational epitope of desmoglein 3 recognized by the autoantibodies in pemphigus vulgaris sera.

Original languageEnglish
Pages (from-to)829-834
Number of pages6
JournalJournal of Investigative Dermatology
Volume115
Issue number5
DOIs
Publication statusPublished - 2000

Fingerprint

Desmoglein 3
Epitope Mapping
Pemphigus
Epitopes
Molecules
Desmoglein 1
Autoantibodies
Serum
Desmosomal Cadherins
Immunosorbents
Baculoviridae
Cell adhesion
Cadherins
Cell Adhesion
Autoimmune Diseases
Conformations
Assays
Enzyme-Linked Immunosorbent Assay

Keywords

  • Autoantibody
  • Autoimmunity
  • Cadherin
  • ELISA

ASJC Scopus subject areas

  • Dermatology

Cite this

Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. / Futei, Y.; Amagai, Masayuki; Sekiguchi, M.; Nishifuji, K.; Fujii, Y.; Nishikawa, T.

In: Journal of Investigative Dermatology, Vol. 115, No. 5, 2000, p. 829-834.

Research output: Contribution to journalArticle

Futei, Y. ; Amagai, Masayuki ; Sekiguchi, M. ; Nishifuji, K. ; Fujii, Y. ; Nishikawa, T. / Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. In: Journal of Investigative Dermatology. 2000 ; Vol. 115, No. 5. pp. 829-834.
@article{565113ad366c4d24b302aaa4727bcae2,
title = "Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris",
abstract = "Pemphigus vulgaris is an autoimmune blistering disease caused by autoantibodies against desmoglein 3, a member of the desmosomal cadherin family. These autoantibodies recognize conformation-dependent epitopes on desmoglein 3. In this study we attempted to map the conformational epitopes of desmoglein 3 in pemphigus vulgaris using recombinant desmoglein 3 produced by the baculovirus expression system. We developed a series of domain-swapped molecules between desmoglein 3 and desmoglein 1, which have similar structures but distinct epitopes. These were developed by substituting deleted segmental regions of desmoglein 3 by the corresponding desmoglein 1. Thus domain-swapped molecules containing desmoglein 3 residues 1-403, 1-161, 163-566, and 405-566 were constructed and used as competitors for competition enzyme-linked immunosorbent assay against the entire extracellular domain of desmoglein 3 with 25 pemphigus vulgaris sera. Considering more than 50{\%} absorption as significant, residues 1-403 and 1-161 showed significant absorption in 24 out of 25 (96{\%}) and 18 out of 25 (72{\%}) pemphigus vulgaris sera, respectively, whereas only one serum and no sera showed significant absorption by residues 163-566 and 405-566, respectively. Furthermore, no apparent change in their major epitopes was seen during the time course in four pemphigus vulgaris cases tested. These findings indicate that the domain-swapping approach is useful for conformational epitope mapping in pemphigus and that amino-terminal residues 1-161, which are considered to include a region essential for cell-cell adhesion in cadherins, contain the critical residues of the conformational epitope of desmoglein 3 recognized by the autoantibodies in pemphigus vulgaris sera.",
keywords = "Autoantibody, Autoimmunity, Cadherin, ELISA",
author = "Y. Futei and Masayuki Amagai and M. Sekiguchi and K. Nishifuji and Y. Fujii and T. Nishikawa",
year = "2000",
doi = "10.1046/j.1523-1747.2000.00137.x",
language = "English",
volume = "115",
pages = "829--834",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris

AU - Futei, Y.

AU - Amagai, Masayuki

AU - Sekiguchi, M.

AU - Nishifuji, K.

AU - Fujii, Y.

AU - Nishikawa, T.

PY - 2000

Y1 - 2000

N2 - Pemphigus vulgaris is an autoimmune blistering disease caused by autoantibodies against desmoglein 3, a member of the desmosomal cadherin family. These autoantibodies recognize conformation-dependent epitopes on desmoglein 3. In this study we attempted to map the conformational epitopes of desmoglein 3 in pemphigus vulgaris using recombinant desmoglein 3 produced by the baculovirus expression system. We developed a series of domain-swapped molecules between desmoglein 3 and desmoglein 1, which have similar structures but distinct epitopes. These were developed by substituting deleted segmental regions of desmoglein 3 by the corresponding desmoglein 1. Thus domain-swapped molecules containing desmoglein 3 residues 1-403, 1-161, 163-566, and 405-566 were constructed and used as competitors for competition enzyme-linked immunosorbent assay against the entire extracellular domain of desmoglein 3 with 25 pemphigus vulgaris sera. Considering more than 50% absorption as significant, residues 1-403 and 1-161 showed significant absorption in 24 out of 25 (96%) and 18 out of 25 (72%) pemphigus vulgaris sera, respectively, whereas only one serum and no sera showed significant absorption by residues 163-566 and 405-566, respectively. Furthermore, no apparent change in their major epitopes was seen during the time course in four pemphigus vulgaris cases tested. These findings indicate that the domain-swapping approach is useful for conformational epitope mapping in pemphigus and that amino-terminal residues 1-161, which are considered to include a region essential for cell-cell adhesion in cadherins, contain the critical residues of the conformational epitope of desmoglein 3 recognized by the autoantibodies in pemphigus vulgaris sera.

AB - Pemphigus vulgaris is an autoimmune blistering disease caused by autoantibodies against desmoglein 3, a member of the desmosomal cadherin family. These autoantibodies recognize conformation-dependent epitopes on desmoglein 3. In this study we attempted to map the conformational epitopes of desmoglein 3 in pemphigus vulgaris using recombinant desmoglein 3 produced by the baculovirus expression system. We developed a series of domain-swapped molecules between desmoglein 3 and desmoglein 1, which have similar structures but distinct epitopes. These were developed by substituting deleted segmental regions of desmoglein 3 by the corresponding desmoglein 1. Thus domain-swapped molecules containing desmoglein 3 residues 1-403, 1-161, 163-566, and 405-566 were constructed and used as competitors for competition enzyme-linked immunosorbent assay against the entire extracellular domain of desmoglein 3 with 25 pemphigus vulgaris sera. Considering more than 50% absorption as significant, residues 1-403 and 1-161 showed significant absorption in 24 out of 25 (96%) and 18 out of 25 (72%) pemphigus vulgaris sera, respectively, whereas only one serum and no sera showed significant absorption by residues 163-566 and 405-566, respectively. Furthermore, no apparent change in their major epitopes was seen during the time course in four pemphigus vulgaris cases tested. These findings indicate that the domain-swapping approach is useful for conformational epitope mapping in pemphigus and that amino-terminal residues 1-161, which are considered to include a region essential for cell-cell adhesion in cadherins, contain the critical residues of the conformational epitope of desmoglein 3 recognized by the autoantibodies in pemphigus vulgaris sera.

KW - Autoantibody

KW - Autoimmunity

KW - Cadherin

KW - ELISA

UR - http://www.scopus.com/inward/record.url?scp=0033731491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033731491&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1747.2000.00137.x

DO - 10.1046/j.1523-1747.2000.00137.x

M3 - Article

C2 - 11069620

AN - SCOPUS:0033731491

VL - 115

SP - 829

EP - 834

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5

ER -